https://www.onhealthcare.tech/p/from-fringe-to-formulary-how-integrativeThoughts on Healthcare Markets and Technologyen2026-04-09T12:48:55+00:00From Fringe to Formulary: How Integrative Medicine, Peptides, and the D2C Biomarker Stack Are Reshaping the Boundaries of Evidence-Based Carehttps://www.onhealthcare.tech/p/the-balance-model-glp-1-coverageThoughts on Healthcare Markets and Technologyen2026-04-08T23:00:17+00:00The BALANCE Model, GLP-1 Coverage, and the Peptide Regulatory Collision: What Every Health Tech Operator and Investor Needs to Know Right Nowhttps://www.onhealthcare.tech/p/the-cy-2027-ma-rate-announcementThoughts on Healthcare Markets and Technologyen2026-04-07T16:40:28+00:00The CY 2027 MA Rate Announcement as an Entrepreneur’s Prospectus